Baloxavir marboxil: the new influenza drug on the market
Current Opinion in Virology（2019）
摘要
•Approval of first endonuclease inhibitor for influenza treatment.•Represents a new class of influenza drug.•Single dose is clinically effective.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要